This Monthly Ozempic Competitor Has Just Achieved Significant Outcomes
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves once each week. In newly released clinical trial data, Amgen’s once-monthly experimental drug MariTide performed as well as or even better than the existing blockbuster GLP-1 medications semaglutide and tirzepatide. People...
Like
Love
Haha
3
0 Commentaires 0 Parts 9KB Vue 0 Aperçu